Plain-English translation of NCT07001631 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Sickle Cell Disease research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a therapy called EMDR (eye movement desensitization and reprocessing) to help children with sickle cell disease manage pain and how it interferes with their daily activities. EMDR is a type of talk therapy that uses guided eye movements to help process painful or traumatic memories. Researchers want to know if this treatment can reduce pain interference, help children feel less anxious or sad, and improve their quality of life.
Children with sickle cell disease often struggle with ongoing pain that disrupts school, friendships, and daily activities. Current pain treatments don't always address how the pain and stress affect a child's emotional well-being. This trial explores whether this therapy could help by treating both the emotional impact of pain and the pain itself.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join the treatment group, you'll start therapy fairly quickly after enrolling. You'll have an intake meeting to plan your care, then attend up to 6 weekly therapy sessions (each about 1 hour long). You'll complete questionnaires about your pain and emotions at the start, then again 2 weeks and 3 months after your sessions end. If you're assigned to the wait-list group, you'll wait 9 weeks before starting the same therapy, and complete similar questionnaires during that time.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
Netherlands